vs

Side-by-side financial comparison of Axalta Coating Systems Ltd. (AXTA) and CME Group (CME). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.3B, roughly 1.5× Axalta Coating Systems Ltd.). Axalta Coating Systems Ltd. runs the higher net margin — 4.8% vs 0.1%, a 4.7% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs -3.7%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs -1.2%).

Axalta Coating Systems Ltd., also known as simply Axalta, is an American company specializing in coatings in a wide variety of industrial applications, materials and sectors, including automotive paints. The company is based in Philadelphia, Pennsylvania, and incorporated in Bermuda. Axalta develops and manufactures coatings for light and commercial vehicles, industrial, and refinish applications. The firm does business in 130 countries, has nearly 13,000 employees, and has more than 100,000 ...

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

AXTA vs CME — Head-to-Head

Bigger by revenue
CME
CME
1.5× larger
CME
$1.9B
$1.3B
AXTA
Growing faster (revenue YoY)
CME
CME
+18.2% gap
CME
14.5%
-3.7%
AXTA
Higher net margin
AXTA
AXTA
4.7% more per $
AXTA
4.8%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
-1.2%
AXTA

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AXTA
AXTA
CME
CME
Revenue
$1.3B
$1.9B
Net Profit
$60.0M
$1.2M
Gross Margin
33.4%
Operating Margin
12.8%
0.1%
Net Margin
4.8%
0.1%
Revenue YoY
-3.7%
14.5%
Net Profit YoY
-56.2%
20.7%
EPS (diluted)
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXTA
AXTA
CME
CME
Q1 26
$1.9B
Q4 25
$1.3B
$1.6B
Q3 25
$1.3B
$1.5B
Q2 25
$1.3B
$1.7B
Q1 25
$1.3B
$1.6B
Q4 24
$1.3B
$1.5B
Q3 24
$1.3B
$1.6B
Q2 24
$1.4B
$1.5B
Net Profit
AXTA
AXTA
CME
CME
Q1 26
$1.2M
Q4 25
$60.0M
$1.2B
Q3 25
$110.0M
$908.0M
Q2 25
$109.0M
$1.0B
Q1 25
$99.0M
$956.2M
Q4 24
$137.0M
$874.6M
Q3 24
$101.0M
$912.8M
Q2 24
$112.0M
$883.2M
Gross Margin
AXTA
AXTA
CME
CME
Q1 26
Q4 25
33.4%
Q3 25
34.9%
Q2 25
35.0%
Q1 25
34.3%
Q4 24
34.1%
Q3 24
35.0%
Q2 24
34.0%
Operating Margin
AXTA
AXTA
CME
CME
Q1 26
0.1%
Q4 25
12.8%
61.8%
Q3 25
15.8%
63.3%
Q2 25
14.8%
66.7%
Q1 25
13.9%
67.5%
Q4 24
14.3%
62.1%
Q3 24
14.6%
64.6%
Q2 24
15.2%
65.3%
Net Margin
AXTA
AXTA
CME
CME
Q1 26
0.1%
Q4 25
4.8%
71.7%
Q3 25
8.5%
59.1%
Q2 25
8.4%
60.6%
Q1 25
7.8%
58.2%
Q4 24
10.5%
57.3%
Q3 24
7.7%
57.6%
Q2 24
8.3%
57.6%
EPS (diluted)
AXTA
AXTA
CME
CME
Q1 26
Q4 25
$0.28
$3.24
Q3 25
$0.51
$2.49
Q2 25
$0.50
$2.81
Q1 25
$0.45
$2.62
Q4 24
$0.63
$2.40
Q3 24
$0.46
$2.50
Q2 24
$0.51
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXTA
AXTA
CME
CME
Cash + ST InvestmentsLiquidity on hand
$657.0M
$2.4B
Total DebtLower is stronger
$3.2B
$3.4B
Stockholders' EquityBook value
$2.3B
Total Assets
$7.6B
$202.0B
Debt / EquityLower = less leverage
1.36×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXTA
AXTA
CME
CME
Q1 26
$2.4B
Q4 25
$657.0M
$4.5B
Q3 25
$606.0M
$2.6B
Q2 25
$625.0M
$2.1B
Q1 25
$575.0M
$1.5B
Q4 24
$593.0M
$3.0B
Q3 24
$567.0M
$2.4B
Q2 24
$840.0M
$1.9B
Total Debt
AXTA
AXTA
CME
CME
Q1 26
$3.4B
Q4 25
$3.2B
Q3 25
$3.4B
Q2 25
$3.4B
Q1 25
$3.4B
Q4 24
$3.4B
Q3 24
$3.5B
Q2 24
$3.6B
Stockholders' Equity
AXTA
AXTA
CME
CME
Q1 26
Q4 25
$2.3B
$28.7B
Q3 25
$2.3B
$28.2B
Q2 25
$2.3B
$27.7B
Q1 25
$2.1B
$27.0B
Q4 24
$1.9B
$26.5B
Q3 24
$1.9B
$28.2B
Q2 24
$1.8B
$27.6B
Total Assets
AXTA
AXTA
CME
CME
Q1 26
$202.0B
Q4 25
$7.6B
$198.4B
Q3 25
$7.8B
$187.1B
Q2 25
$7.8B
$179.9B
Q1 25
$7.4B
$157.8B
Q4 24
$7.2B
$137.4B
Q3 24
$7.5B
$137.8B
Q2 24
$7.3B
$123.4B
Debt / Equity
AXTA
AXTA
CME
CME
Q1 26
Q4 25
1.36×
Q3 25
1.48×
Q2 25
1.50×
Q1 25
1.64×
Q4 24
1.78×
Q3 24
1.84×
Q2 24
2.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXTA
AXTA
CME
CME
Operating Cash FlowLast quarter
$344.0M
Free Cash FlowOCF − Capex
$286.0M
FCF MarginFCF / Revenue
22.7%
Capex IntensityCapex / Revenue
4.6%
Cash ConversionOCF / Net Profit
5.73×
TTM Free Cash FlowTrailing 4 quarters
$453.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXTA
AXTA
CME
CME
Q1 26
Q4 25
$344.0M
$1.1B
Q3 25
$137.0M
$968.1M
Q2 25
$142.0M
$1.1B
Q1 25
$26.0M
$1.1B
Q4 24
$234.0M
$1.0B
Q3 24
$194.0M
$1.0B
Q2 24
$114.0M
$776.9M
Free Cash Flow
AXTA
AXTA
CME
CME
Q1 26
Q4 25
$286.0M
$1.1B
Q3 25
$87.0M
$949.7M
Q2 25
$97.0M
$1.0B
Q1 25
$-17.0M
$1.1B
Q4 24
$172.0M
$991.7M
Q3 24
$161.0M
$973.2M
Q2 24
$91.0M
$758.7M
FCF Margin
AXTA
AXTA
CME
CME
Q1 26
Q4 25
22.7%
66.8%
Q3 25
6.8%
61.8%
Q2 25
7.4%
61.5%
Q1 25
-1.3%
67.1%
Q4 24
13.1%
65.0%
Q3 24
12.2%
61.4%
Q2 24
6.7%
49.5%
Capex Intensity
AXTA
AXTA
CME
CME
Q1 26
Q4 25
4.6%
2.0%
Q3 25
3.9%
1.2%
Q2 25
3.4%
1.1%
Q1 25
3.4%
0.9%
Q4 24
4.7%
1.7%
Q3 24
2.5%
1.9%
Q2 24
1.7%
1.2%
Cash Conversion
AXTA
AXTA
CME
CME
Q1 26
Q4 25
5.73×
0.96×
Q3 25
1.25×
1.07×
Q2 25
1.30×
1.03×
Q1 25
0.26×
1.17×
Q4 24
1.71×
1.16×
Q3 24
1.92×
1.10×
Q2 24
1.02×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXTA
AXTA

Refinish$509.0M40%
Light Vehicle$372.0M29%
Industrial$282.0M22%
Commercial Vehicle$99.0M8%

CME
CME

Segment breakdown not available.

Related Comparisons